-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DIHcdCq882FGVaIrbLkPUy6GhShgfR4lDrWxQPZUYUxxfGxQTDai8BQh5X9/bbin Q3KG0lo3NF3E1lIVKL80HA== 0000893838-97-000148.txt : 19970925 0000893838-97-000148.hdr.sgml : 19970925 ACCESSION NUMBER: 0000893838-97-000148 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970924 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDIMMUNE INC /DE CENTRAL INDEX KEY: 0000873591 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 521555759 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-42057 FILM NUMBER: 97684992 BUSINESS ADDRESS: STREET 1: 35 W WATKINS MILL RD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 3014170770 MAIL ADDRESS: STREET 1: 35 W WATKINS MILL ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: HONER BERND DIETHELM CENTRAL INDEX KEY: 0000922846 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: C/O SUMMIT ASSET MANAGEMENT CO INC STREET 2: 666 PLAINSBORO RD #445 CITY: PLAINSBORO STATE: NJ ZIP: 08536 MAIL ADDRESS: STREET 1: C/O SUMMIT ASSET MANAGEMENT CO INC STREET 2: 666 PLAINSBORO RD #445 CITY: PLAINSBORO STATE: NJ ZIP: 08536 SC 13D/A 1 SCHEDULE 13D AMENDMENT NO. 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* MedImmune, Inc. ------------------------------------------------------- (Name of Issuer) Common Stock, par value $0.01 per share - ------------------------------------------------------------------------------- (Title of Class of Securities) 584699102 ------------------------------------------------------- (CUSIP Number) Bernd Diethelm Honer c/o Summit Asset Management Co., Inc. Suite 445 666 Plainsboro Rd. Plainsboro, NJ 08536 609-275-1890 - ------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) September 16, 1997 - ------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) - ------------------------------------------------------------------------------- If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box |_| Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13D CUSIP No. 584699102 Page 2 of 4 Pages 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Bernd Diethelm Honer 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| 3 SEC USE ONLY 4 SOURCE OF FUNDS* OO 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| 6 CITIZENSHIP OR PLACE OF ORGANIZATION Federal Republic of Germany NUMBER OF 7 SOLE VOTING POWER SHARES 1,162,406 BENEFICIALLY 8 SHARED VOTING POWER OWNED BY -0- EACH 9 SOLE DISPOSITIVE POWER REPORTING 1,162,406 PERSON 10 SHARED DISPOSITIVE POWER WITH -0- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,162,406 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.89% 14 TYPE OF REPORTING PERSON* IN *SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION. - ------------------------------------------------------------------------------- CUSIP NO. 584699102 SCHEDULE 13D Page 3 of 4 Pages - ------------------------------------------------------------------------------- This Amendment No. 3 ("Amendment No. 3") amends the Schedule 13D filed by Bernd Diethelm Honer (the "Reporting Person") with the Securities and Exchange Commission on January 21, 1997 and previously amended on July 9 and September 15, 1997, respectively. Amendment No. 3 relates to sales of shares of the Common Stock, par value $0.01 per share (the "Shares"), of MedImmune, Inc. (the "Issuer") by Mr. Honer on September 15 and September 16, 1997. As of September 16, 1997 Mr. Honer's beneficial ownership of Shares of the Issuer dropped below 5% to 4.89% and, as a result, Mr. Honer's obligation to report material acquisitions or dispositions of Shares on Schedule 13D is terminated. Item 5. Interest in Securities of the Issuer. (a) As of September 16, 1997, Mr. Honer was the beneficial owner of 1,162,406 Shares, which represents approximately 4.89% of the outstanding Shares of the Issuer. This percentage has been calculated from information received from the Issuer's management. (b) Mr. Honer has sole power to vote or direct the vote and sole power to dispose or direct the disposition of all Shares beneficially owned by him. Mr. Honer does not share the power to vote or direct the disposition of any Shares beneficially owned by him. (c) The following transactions were effected by the Reporting Person since the most recent filing on Schedule 13D by the Reporting Person and through September 16, 1997. Transaction Date Security No. Price/Share Market ----------- ---- -------- --- ----------- ------ Sale 9/15/97 Common 10,000 $28.438 NASDAQ Sale 9/15/97 Common 20,000 $28.469 NASDAQ Sale 9/16/97 Common 50,000 $28.500 NASDAQ Sale 9/16/97 Common 25,000 $28.625 NASDAQ (d) None. (e) Not applicable. - ------------------------------------------------------------------------------- CUSIP NO. 584699102 SCHEDULE 13D Page 4 of 4 Pages - ------------------------------------------------------------------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I hereby certify that the information set forth in this Statement is true, complete and correct. Dated: September 24, 1997 BERND DIETHELM HONER By: /s/ Scott M. Ciccone Scott M. Ciccone, as duly authorized attorney-in-fact* - -------- * Power of attorney previously filed as an exhibit to Amendment No. 1 to Schedule 13D on July 9, 1997. -----END PRIVACY-ENHANCED MESSAGE-----